Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leah M Prentice

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2020
Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation statusBasile Tessier-Cloutier, Kim E Kortekaas, Emily Thompson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2013
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profilesMelissa K McConechy, Jiarui Ding, Janine Senz, et al.
Oncogene|July 20, 2005
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosisLeah M Prentice, Ashleen Shadeo, Valia S Lestou, et al.
The Journal of Pathology|February 19, 2015
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burdenMichael S Anglesio, Ali Bashashati, Yi Kan Wang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 20, 2022
The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practiceHui-Lin Chin, Nour Gazzaz, Stephanie Huynh, et al.
Genome Research|July 26, 2014
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence dataGavin Ha, Andrew Roth, Jaswinder Khattra, et al.
The Journal of Pathology|March 8, 2011
Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomasMelissa K McConechy, Michael S Anglesio, Steve E Kalloger, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219Barbara Melosky, Penelope Bradbury, Dongsheng Tu, et al.
Frontiers in Medicine|January 30, 2023
The practice of genomic medicine: A delineation of the process and its governing principlesJulia Handra, Adrienne Elbert, Nour Gazzaz, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2020
Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation statusBasile Tessier-Cloutier, Kim E Kortekaas, Emily Thompson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2013
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profilesMelissa K McConechy, Jiarui Ding, Janine Senz, et al.
Oncogene|July 20, 2005
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosisLeah M Prentice, Ashleen Shadeo, Valia S Lestou, et al.
The Journal of Pathology|February 19, 2015
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burdenMichael S Anglesio, Ali Bashashati, Yi Kan Wang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 20, 2022
The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practiceHui-Lin Chin, Nour Gazzaz, Stephanie Huynh, et al.
Genome Research|July 26, 2014
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence dataGavin Ha, Andrew Roth, Jaswinder Khattra, et al.
The Journal of Pathology|March 8, 2011
Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomasMelissa K McConechy, Michael S Anglesio, Steve E Kalloger, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219Barbara Melosky, Penelope Bradbury, Dongsheng Tu, et al.
Frontiers in Medicine|January 30, 2023
The practice of genomic medicine: A delineation of the process and its governing principlesJulia Handra, Adrienne Elbert, Nour Gazzaz, et al.
Pageof 3